Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Effect of application route of the ghrelin analog BIM-28131 (RM-131) on body weight and body composition in a rat heart failure model.

Palus S, von Haehling S, Doehner W, Datta R, Zhang J, Dong JZ, Culler MD, Anker SD, Springer J.

Int J Cardiol. 2013 Oct 3;168(3):2369-74. doi: 10.1016/j.ijcard.2013.01.263. Epub 2013 Mar 7.

PMID:
23465234
2.

Ghrelin and its analogues, BIM-28131 and BIM-28125, improve body weight and regulate the expression of MuRF-1 and MAFbx in a rat heart failure model.

Palus S, Schur R, Akashi YJ, Bockmeyer B, Datta R, Halem H, Dong J, Culler MD, Adams V, Anker SD, Springer J.

PLoS One. 2011;6(11):e26865. doi: 10.1371/journal.pone.0026865. Epub 2011 Nov 15.

3.

No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure.

Akashi YJ, Palus S, Datta R, Halem H, Taylor JE, Thoene-Reineke C, Dong J, Thum T, Culler MD, Anker SD, Springer J.

Int J Cardiol. 2009 Nov 12;137(3):267-75. doi: 10.1016/j.ijcard.2008.06.094. Epub 2008 Aug 23.

PMID:
18723230
4.

Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure.

Nagaya N, Uematsu M, Kojima M, Ikeda Y, Yoshihara F, Shimizu W, Hosoda H, Hirota Y, Ishida H, Mori H, Kangawa K.

Circulation. 2001 Sep 18;104(12):1430-5.

5.

Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia.

DeBoer MD, Zhu XX, Levasseur P, Meguid MM, Suzuki S, Inui A, Taylor JE, Halem HA, Dong JZ, Datta R, Culler MD, Marks DL.

Endocrinology. 2007 Jun;148(6):3004-12. Epub 2007 Mar 8.

PMID:
17347304
6.

Long-term effects of ghrelin and ghrelin receptor agonists on energy balance in rats.

Strassburg S, Anker SD, Castaneda TR, Burget L, Perez-Tilve D, Pfluger PT, Nogueiras R, Halem H, Dong JZ, Culler MD, Datta R, Tschöp MH.

Am J Physiol Endocrinol Metab. 2008 Jul;295(1):E78-84. doi: 10.1152/ajpendo.00040.2008. Epub 2008 May 6.

7.

Effect of ghrelin and its analogues, BIM-28131 and BIM-28125, on the expression of myostatin in a rat heart failure model.

Lenk K, Palus S, Schur R, Datta R, Dong J, Culler MD, Anker S, Springer J, Schuler G, Adams V.

J Cachexia Sarcopenia Muscle. 2013 Mar;4(1):63-9. doi: 10.1007/s13539-012-0085-3. Epub 2012 Sep 18.

8.

A novel growth hormone secretagogue-1a receptor antagonist that blocks ghrelin-induced growth hormone secretion but induces increased body weight gain.

Halem HA, Taylor JE, Dong JZ, Shen Y, Datta R, Abizaid A, Diano S, Horvath TL, Culler MD.

Neuroendocrinology. 2005;81(5):339-49. Epub 2005 Oct 5.

PMID:
16210868
9.

The role of hypertrophy and growth factors in heart failure.

Ross J Jr, Hongo M.

J Card Fail. 1996 Dec;2(4 Suppl):S121-8.

PMID:
8951569
10.

Growth hormone improves cardiac function in rats with experimental myocardial infarction.

Isgaard J, Kujacic V, Jennische E, Holmäng A, Sun XY, Hedner T, Hjalmarson A, Bengtsson BA.

Eur J Clin Invest. 1997 Jun;27(6):517-25.

PMID:
9229233
11.

The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction.

Tivesten A, Bollano E, Caidahl K, Kujacic V, Sun XY, Hedner T, Hjalmarson A, Bengtsson BA, Isgaard J.

Endocrinology. 2000 Jan;141(1):60-6.

PMID:
10614623
12.

Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction.

Soeki T, Kishimoto I, Schwenke DO, Tokudome T, Horio T, Yoshida M, Hosoda H, Kangawa K.

Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H426-32. Epub 2007 Nov 16.

PMID:
18024547
13.

GSK1614343, a novel ghrelin receptor antagonist, produces an unexpected increase of food intake and body weight in rodents and dogs.

Costantini VJ, Vicentini E, Sabbatini FM, Valerio E, Lepore S, Tessari M, Sartori M, Michielin F, Melotto S, Bifone A, Pich EM, Corsi M.

Neuroendocrinology. 2011;94(2):158-68. doi: 10.1159/000328968. Epub 2011 Jul 22. Erratum in: Neuroendocrinology. 2012;95(3):247. Bifone, Angelo [added].

PMID:
21778696
14.

Chronic olanzapine administration in rats: effect of route of administration on weight, food intake and body composition.

Mann S, Chintoh A, Giacca A, Fletcher P, Nobrega J, Hahn M, Remington G.

Pharmacol Biochem Behav. 2013 Feb;103(4):717-22. doi: 10.1016/j.pbb.2012.12.002. Epub 2012 Dec 9.

PMID:
23234835
15.

Recombinant human growth hormone secreted from tissue-engineered bioartificial muscle improves left ventricular function in rat with acute myocardial infarction.

Rong SL, Wang YJ, Wang XL, Lu YX, Chang C, Wang FZ, Liu QY, Liu XY, Gao YZ, Mi SH.

Chin Med J (Engl). 2009 Oct 5;122(19):2352-9.

PMID:
20079139
16.

Glucocorticoid-dependent stimulation of adiposity and appetite by a ghrelin mimetic in the rat.

Tung YL, Hewson AK, Dickson SL.

Eur J Endocrinol. 2004 Jun;150(6):905-11.

17.

Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition.

Jin H, Yang R, Gillett N, Clark RG, Ko A, Paoni NF.

J Cardiovasc Pharmacol. 1995 Sep;26(3):420-5.

PMID:
8583784
18.

The somatostatin subtype-2 receptor antagonist, BIM-23627, improves the catabolic effects induced by long-term glucocorticoid treatment in the rat.

Tulipano G, Rossi E, Culler MD, Taylor JE, Bonadonna S, Locatelli V, Cocchi D, Giustina A.

Regul Pept. 2005 Feb 15;125(1-3):85-92.

PMID:
15582718
19.

Glucocorticoid inhibition of growth in rats: partial reversal with the full-length ghrelin analog BIM-28125.

Tulipano G, Taylor JE, Halem HA, Datta R, Dong JZ, Culler MD, Bianchi I, Cocchi D, Giustina A.

Pituitary. 2007;10(3):267-74.

PMID:
17587180
20.

Similar cardiovascular effects of growth hormone and insulin-like growth factor-I in rats after experimental myocardial infarction.

Tivesten A, Caidahl K, Kujacic V, Sun XY, Hedner T, Bengtsson BA, Isgaard J.

Growth Horm IGF Res. 2001 Jun;11(3):187-95.

PMID:
11735233

Supplemental Content

Support Center